Pro-resolving lipid mediator Resolvin D1 serves as a marker of lung disease in cystic fibrosis.

by Olaf Eickmeier, Daniela Fussbroich, Klaus Mueller, Friederike Serve, Christina Smaczny, Stefan Zielen, Ralf Schubert
Published 2017-01-01

Diabetes in cystic fibrosis: multicenter screening results based on current guidelines.

by Nicole Scheuing, Reinhard W Holl, Gerd Dockter, Katharina Fink, Sibylle Junge, Lutz Naehrlich, Christina Smaczny, Doris Staab, Gabriela Thalhammer, Silke van Koningsbruggen-Rietschel, Manfred Ballmann
Published 2013-01-01

High variability in oral glucose tolerance among 1,128 patients with cystic fibrosis: a multicenter screening study.

by Nicole Scheuing, Reinhard W Holl, Gerd Dockter, Julia M Hermann, Sibylle Junge, Cordula Koerner-Rettberg, Lutz Naehrlich, Christina Smaczny, Doris Staab, Gabriela Thalhammer, Silke van Koningsbruggen-Rietschel, Manfred Ballmann
Published 2014-01-01

Sequential Inhalational Tobramycin-Colistin-Combination in CF-Patients with Chronic P. Aeruginosa Colonization - an Observational Study

by Joachim Riethmüller, Gloria Herrmann, Ute Graepler-Mainka, Dorothea Hellwig, Hans-Eberhard Heuer, Susanne Heyder, Holger Köster, Birte Kinder, Kristina Kröger, Klaus Paul, Krystyna Poplawska, Volker O. Melichar, Christina Smaczny, Uwe Mellies
Published 2016-08-01

Impact of a Gap Junction Protein Alpha 4 Variant on Clinical Disease Phenotype in F508del Homozygous Patients With Cystic Fibrosis

by Tabea Horn, Michael Ludwig, Olaf Eickmeier, Anne H. Neerinex, Anke H. Maitland-van der Zee, Anke H. Maitland-van der Zee, Christina Smaczny, Thomas O. F. Wagner, Ralf Schubert, Stefan Zielen, Christof Majoor, Lieuwe D. Bos, Lieuwe D. Bos, Sabina Schmitt-Grohé, Sabina Schmitt-Grohé
Published 2020-10-01